I am still a bit bemused by the wording of the announcement.
”FDA has informed the company that following additional consideration the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission”
Note - not “data”, not “new information”, but “consideration”.
Were the FDA head honchos having a round of golf, and decided amongst themselves that they had been a bit hard on the Aussie battler? Then back to the clubhouse for a scotch or three.
Or perhaps Big Pharma have “advised” the FDA top order that Meso's gonads have been squeezed enough, so give them a win that also allows BP to make a cheap TO?
Don't get me wrong. My wife is very happy to see the reverse in fortunes, and so quick after that dilutive capital raise too!
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-451
-
-
- There are more pages in this discussion • 642 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.00 |
Change
0.020(2.04%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 99.0¢ | $2.896M | 2.885M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
76 | 241354 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 30701 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
73 | 225927 | 1.000 |
14 | 119215 | 0.995 |
19 | 104509 | 0.990 |
10 | 228758 | 0.985 |
11 | 567124 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 25059 | 8 |
1.010 | 227014 | 19 |
1.015 | 169948 | 21 |
1.020 | 114248 | 18 |
1.025 | 144549 | 11 |
Last trade - 12.59pm 28/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online